Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)

Clinical trial NCT00407719 · COMPLETED

Trial details

NCT number: NCT00407719
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Choroidal Neovascularization Degenerative Myopia Pathological Myopia

Start date: 2005-06-01
Primary completion: 2007-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.